Axial Healthcare, Inc. – Trademark Portfolio
Entity Type: 03
Axial Healthcare, Inc. holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 14 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include WAYSPRING, AXIALPRACTICE, AXIAL HEALTHCARE, and WAYSPRING CLINIC. The owner is based in Nashville, TN.
Suite 332
209 10th Avenue South
Nashville, TN 37203
Showing of trademarks Trademarks
Trademark Classifications
Axial Healthcare, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Axial Healthcare, Inc. have?
Axial Healthcare, Inc. has 20 U.S. trademarks filed with the USPTO. Of these, 6 registered, 11 abandoned, 3 cancelled.
What trademark classes does Axial Healthcare, Inc. file in?
Axial Healthcare, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Axial Healthcare, Inc.'s most well-known trademarks?
Axial Healthcare, Inc.'s registered trademark portfolio includes well-known marks such as WAYSPRING, AXIALPRACTICE, AXIAL HEALTHCARE, and WAYSPRING CLINIC. These are among 6 currently registered trademarks in the portfolio.
What is Axial Healthcare, Inc.'s trademark registration success rate?
Axial Healthcare, Inc. has a 30% trademark registration rate, with 6 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.